| Ketones bodies as potential key regulator in the cardiovascular-kidney-metabolic syndrome | |  | | 2026 | 15 | 1 |
|
| Dépister et ralentir l’apparition du diabète de type 1 : un nouveau paradigme | Revue médicale suisse |  | | 2025 | 39 | 0 |
|
| Quelle diète pour la néphroprotection dans la maladie rénale chronique ? | Revue médicale suisse |  | | 2025 | 132 | 13 |
|
| Case Report : Extreme resistance to subcutaneous insulin in a cirrhotic patient with new-onset diabetes that resolved after transplantation | Frontiers in endocrinology |  | | 2025 | 45 | 196 |
|
| Self-reported perceptions of adults with diabetes regarding their care and health in the time of COVID-19 pandemic in a Swiss region : a cross-sectional study | Swiss medical weekly |  | | 2024 | 28 | 59 |
|
| Effects of empagliflozin on reproductive system in men without diabetes | Scientific reports |  | | 2024 | 66 | 115 |
|
| Mesures du glucose non invasives : où en est-on ? | Revue médicale suisse |  | | 2024 | 90 | 16 |
|
| Pied diabétique : une prise en charge complexe et multidisciplinaire | Revue médicale suisse |  | | 2023 | 139 | 56 |
|
| Cardio-Metabolic and Mental Health Outcomes Before and During the COVID-19 Pandemic in a Cohort of Women With Gestational Diabetes Mellitus in Switzerland | Frontiers in endocrinology |  | | 2022 | 16 | 43 |
|
| Impact of Risk Factors on Short and Long-Term Maternal and Neonatal Outcomes in Women With Gestational Diabetes Mellitus : A Prospective Longitudinal Cohort Study | Frontiers in endocrinology |  | | 2022 | 18 | 39 |
|
| Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on β-Cell Function at 1 Year After Surgery : A Systematic Review | The Journal of clinical endocrinology and metabolism |  | | 2022 | 21 | 185 |
|
| Efficacy of Ketogenic Diets on Type 2 Diabetes : a Systematic Review | Current diabetes report |  | | 2021 | 18 | 285 |
|
| A Single Load of Fructose Attenuates the Risk of Exercise-Induced Hypoglycemia in Adults With Type 1 Diabetes on Ultra-Long-Acting Basal Insulin : A Randomized, Open-Label, Crossover Proof-of-Principle Study | Diabetes care |  | | 2020 | 20 | 68 |
|